Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
gene therapy
life sciences
novartis
3
×
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
spinal muscular atrophy
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
zolgensma
adaptive biotechnologies
administration
alicrocumab
alzheimer's
american academy of neu
american academy of neurology
amgen
What
healthcare
3
×
bio
life
moves
public
roundup
america
becker
billions
biogen
biotech
continues
convoluted
democrats
dollars
dreams
driving
drug
eaton
gene
good
head
headaches
history
holding
impact
improved
industry
innovation
innovations
insurance
investment
ipo
long
medical
michael
millions
outcomes
patients
previews
Language
unset
Current search:
novartis
×
healthcare
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More